Amorphous solid dispersion technique for improved drug delivery: basics to clinical applications.

about

Characterization and Bioavailability of Wogonin by Different Administration Routes in Beagles.

P2860

Q41505847-FDAA385E-B4A3-45CD-B9B3-816BA840F787

P2860

Amorphous solid dispersion technique for improved drug delivery: basics to clinical applications.

Item

http://www.wikidata.org/entity/Q38573658

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Amorphous solid dispersion tec ...... sics to clinical applications.

@en

type

Item

label

Amorphous solid dispersion tec ...... sics to clinical applications.

@en

prefLabel

Amorphous solid dispersion tec ...... sics to clinical applications.

@en

P1476

Amorphous solid dispersion tec ...... sics to clinical applications.

@en

P2093

Arpit Bhargava

http://www.w3.org/2001/XMLSchema#string

Dinesh Kumar Jain

http://www.w3.org/2001/XMLSchema#string

Dinesh Kumar Mishra

http://www.w3.org/2001/XMLSchema#string

Pradyumna Kumar Mishra

http://www.w3.org/2001/XMLSchema#string

Vinod Dhote

http://www.w3.org/2001/XMLSchema#string

P2860

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs.

Improving drug solubility for oral delivery using solid dispersions.

Phase I trial of 2-methoxyestradiol NanoCrystal dispersion in advanced solid malignancies.

The mechanisms of drug release from solid dispersions in water-soluble polymers.

Preparation and evaluation of sustained-release solid dispersions co-loading gastrodin with borneol as an oral brain-targeting enhancer.

Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system.

Drug delivery strategies for poorly water-soluble drugs.

Pharmaceutical applications of hot-melt extrusion: part I.

Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.

P2888

s13346-015-0256-9

P304

552-565

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13346-015-0256-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281305912

http://www.w3.org/2001/XMLSchema#string

P6179

1053616511

http://www.w3.org/2001/XMLSchema#string

P698

26306524

http://www.w3.org/2001/XMLSchema#string

P921

drug delivery

Amorphous solid dispersion technique for improved drug delivery: basics to clinical applications.

about

P2860

P2860

Amorphous solid dispersion technique for improved drug delivery: basics to clinical applications.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921